Fig. 5   A  %  Viability  of  A549  (non-small  cell  lung  cancer)  and  PC3  (prostate)  human  cancer  cell  lines  (after  72  h)  at  5.0  µM  concentra- tion  of  compounds  1–6.  B  Dose–response  of  compound  1  against  A549  (non-small  cell  lung  cancer)  human  cancer  cell  line  (72  h).  C  